Change the odds:
Uniting to improve cancer outcomes
In recognition and celebration of Pfizer and Seagen coming together, we are proud to collaborate with the American Cancer Society to tackle inequalities in cancer care. Together, we recently launched a new multi-year initiative to help improve health outcomes in medically underrepresented communities across the United States by enhancing awareness of and access to cancer screenings, clinical trial opportunities and patient support and navigation.
We are proud to partner with the American Cancer Society on a community-focused initiative to reach people with cancer where they are and connect them to resources to receive the care they deserve.
Advancing with science
Pfizer’s dedicated oncology team is urgently working to discover, test, and deliver transformative treatments for some of the world’s most prevalent cancers.
Explore the cancer areas that Pfizer is focused on, including the challenges of these diseases and how Pfizer is working to develop the treatments to overcome them.
Breast
Breast cancer is the most common cancer among women in the U.S. with 1 in 8 women and a small percentage of men having a diagnosis in their lifetimes.1 In 2024, over 310,000 women and over 2,700 men will be diagnosed with breast cancer in the U.S.2
Prostate
Prostate cancer is the most common cancer in men in the U.S., aside from non-melanoma skin cancer, and is a leading cause of death from cancer.2 About 1 in 8 men will be diagnosed with prostate cancer
Bladder
Bladder cancer is the 6th most common cancer in the U.S.5 In 2024, an estimated 80,000 new cases of bladder cancer will be diagnosed in the U.S.2 Men are four times more likely to be diagnosed with bladder cancer than women.2
Kidney
Kidney cancer (also known as renal cancer or renal cell adenocarcinoma) in the U.S. is the 6th most common cancer in men and the 9th in women.2 In 2024, an estimated 80,000 new cases of kidney cancer will be diagnosed in the U.S.2
Multiple Myeloma
Multiple myeloma (MM) is a blood cancer that affects cells made in the bone marrow, specifically plasma cells, that are an important part of the body’s immune system. More than 35,000 people are diagnosed with MM in the U.S. every year, making it the second most common type of blood cancer.8
Leukemia
Leukemia is a broad term for blood cancer. Leukemia causes the bone marrow to produce large amounts of abnormal blood cells, which make it hard for healthy cells to do their jobs.11
Lymphoma
Lymphoma is a type of cancer that starts in cells that are a part of the body’s immune system.12 The two main types are Hodgkin lymphoma and non-Hodgkin lymphoma (NHL).
Melanoma
Melanoma skin cancer is the 5th most common cancer in the U.S. and causes the majority of skin cancer deaths.14,15 Melanoma is considered dangerous because it is likely to invade nearby tissue and spread to other parts of the body if not caught and treated early.
Colorectal
Colorectal cancer (CRC) affects the large intestine (including the colon and rectum). They are part of the digestive system, which processes foods for energy and waste.17,18
Cervical
Cervical cancer begins in the cervix, which is found in the lower part of the uterus that connects to the vagina.19 In 2024, an estimated over 13,000 new cases of cervical cancer will be diagnosed in the U.S.2
Lung
Lung cancer remains the leading cause of cancer-related death among men and women, and it is the second most common cancer in the U.S.24 In 2024, an estimated over 230,000 new cases of lung cancer will be diagnosed in the U.S.
Head & Neck
Head and neck cancers occur in the larynx, throat, lips, mouth, nose, and salivary glands.26 About 4% of all cancers in the U.S. are head and neck cancers.27
Stories of strength
Discover the inspiring stories of real people living with cancer.
Derrick
Derrick shares his personal story of his clinical trial participation, offering hope and inspiration to others.
Cynthia
Cynthia shares her journey and message of living life to the fullest, embracing healing, and leaving a lasting light for others to follow.
Jordan
Jordan's path to medical school, coupled with a cancer diagnosis, has been a journey marked by resilience and the unwavering support of loved ones.
Lindsay
Lindsay, an oncology nurse, faced the diagnosis of stage III colorectal cancer at age 33, but her experience has given her a deeper understanding and empathy for her patients.
Here’s to science. Here’s to the
next fight.
Yesterday’s breakthroughs help make a world where people with cancer live better and longer lives possible. As we celebrate over 175 years of impacting people's lives, we invite you to learn more about some of history’s scientific pioneers.